Free Republic

Former First Lady Barbara Bush, 92, decided Sunday to focus on comfort care in the face of her failing health, rather than additional medical treatment. “Following a recent series of hospitalizations, and after consulting her family and doctors, Mrs. Bush, now age 92, has decided not to seek additional medical treatment, and instead will focus on comfort care,” read a statement from the office of George H. W. Bush. Bush has been in an out of the hospital the past year battling chronic obstructive pulmonary disease (COPD) and congestive heart failure. The former first lady has been married to former...

Former first lady Barbara Bush is in failing health, a source close to the Bush family tells CNN. At 92 years old, Bush has been suffering for some time and has been in and out of the hospital multiple times in the last year while battling with Chronic Obstructive Pulmonary Disease, or COPD, and congestive heart failure. The source said she is being cared for at her home in Houston and has decided she does not want to go back into the hospital.

Still coughing on the plane.

Hillary Clinton's Cough Has Returned (Hillary Clinton & Tim Kaine Rally in Cleveland, Ohio (September 5, 2016) Donald Trump vs Hillary Clinton Speeches & Events)

Hillary Clinton began a Labor Day rally in Cleveland with a bad cough — which she blamed on her opponent, Donald Trump. “Every time I think about Trump, I get allergic,” Clinton said after some sustained hacking. “Boy, we have 63 days to go,” Clinton croaked, before coughing some more.

Hillary Clinton Started To Cough Violently In Cleveland, Ohio

Hillary Clinton had a massive coughing fit as she began a campaign rally in Cleveland, Ohio. She had trouble speaking and thanking local elected officials and had to stop multiple times to cough and clear her throat.

Nuclear fusion hits energy milestone Total energy input still far higher than output For the first time, fuel for a nuclear fusion reaction has generated more energy than put into it – a scientific milestone. Scientists and futurists have long dreamed of harnessing the energy of nuclear fusion, which powers the sun, here on Earth. An enormous amount of energy is released when multiple atoms collide and fuse to form a new, heavier atom — such as hydrogen fusing into helium. Hydrogen fuel is plentiful in sources such as seawater and the fusion process generates no radioactive waste, greenhouse gases...

Vitals Major Finding: Eplerenone reduced the risk of cardiovascular death or heart failure hospitalization by 37%, compared with placebo. Data Source: Phase III randomized trial in 2,737 patients with NYHA class II heart failure. Disclosures: EMPHASIS-HF was funded by Pfizer. Dr. Zannad reported receiving grants from and consulting for Pfizer. Two coauthors are Pfizer employees, and several others reported Pfizer grants and consultancy. CHICAGO — Adding eplerenone to standard therapy significantly cut the risk of cardiovascular death and heart failure hospitalization by more than one-third in patients with mild heart failure in the phase III EMPHASIS-HF trial. The primary composite...

CHICAGO — Although Hispanics are grossly underrepresented in heart failure trials, emerging evidence suggests they have unique risk factors and heart failure outcomes that must be taken into clinical consideration. The evidence also underscores the importance of recognizing the vast heterogeneity of Hispanics, Dr. Ileana Piña said at a meeting sponsored by the International Society on Hypertension in Blacks. “Hispanics represent a cultural group, not a racially identifiable group,” said the Cuban-born cardiologist. “You can't lump them all together.” But that's exactly what has happened. Until the Medicare enrollment files were changed in 1994, Hispanics or Native Americans were simply...

N.E. Journal Of Medicine: 1 In 100 African Americans Will Develop The Problem In The Prime Of Life -- Before 50 Heart failure affects about 5 million Americans and is the leading cause of hospitalization in people older than 65, but new research suggests it's not just a disease of the elderly. And for people of color, it's striking remarkably early. One in 100 black men and women will develop heart failure in the prime of life. It's usually the disease of the older set, but according to a study in the New England Journal of Medicine, surprisingly it's striking...

Study: Stem Cells Used To Fix Your Broken Heart It's Called The Marvel Study The Largest Clinical Trial Investigating Adult Stem Cells To Treat Congestive Heart Failure For More Info, Call Jim Moran Heart & Vascular Center At (954) 229-8400 MIAMI (CBS4) ― Doctors are discovering a new way to fix your broken heart. A study is underway in South Florida that could revolutionize the way heart attack patients help their damaged hearts by using their own stem cells. It's called The Marvel Study and under the direction of Dr. Alan Neiderman with the Jim Moran Heart & Vascular Research...

Researchers at the Minneapolis Heart Institute Foundation have launched a study to examine whether administration of stem cells to first time heart attack patients can prevent the development of congestive heart failure (CHF). CHF diagnosis is the cause of hospitalization in the United States and is responsible for more than 50,000 deaths a year. Currently, heart transplantation is the only available cure.  Each year more than one million Americans have their first heart attack, putting them at risk of developing CHF as a result of cardiac cell death and scar formation which results in diminished pumping ability of the heart...

ERUSALEM - After 61 years of pumping blood, Marie Carty's heart was failing her. Months earlier she had given up her two-mile walk on the boardwalk of her New Jersey hometown along the Atlantic Ocean. She could barely make it from the parking lot to the view of the water. Although Carty knew she needed a new heart, she was afraid hers wouldn't last during the long wait for a transplant. Desperate for an alternative, Carty found the Israeli-Thai company Theravitae, which has begun performing an experimental procedure that multiplies stem cells taken from a patient's own blood and injects...

Research Presented at American College of Cardiology Annual Scientific Session Reports D-Ribose Improves Ventilatory Efficiency in Congestive Heart Failure Patients MINNEAPOLIS, Mar. 18 /PRNewswire/ -- MINNEAPOLIS, March 18 /PRNewswire/ -- Ventilatory efficiency is recognized as an important predictor of survival and disease progression among patients with congestive heart failure (CHF). Thus, improving ventilatory efficiency in this population is of prime importance. A research report presented at the American College of Cardiology's Annual Scientific Session 2005 in Orlando, Florida, suggests that D-Ribose can play a significant role in this key pursuit.It is well accepted that failing hearts are energy starved...